STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive: STAT5A/B are upregulated in myeloproliferative neoplasms, acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), and B-cell and peripheral T-cell leukemia/lymphoma [51].